2020 Autumn Conference Posters

Click title to view pdf. Posters are listed in alpha order by first author.

ADVANCE: adherence to antipsychotic and adjunctive pimavanserin in patients with negative symptoms of schizophrenia (Abstract)

Abbs

A pilot study of speech acoustics and placebo responsiveness (Abstract)

Begel

An analysis of clinical outcome assessment trends for neurological and psychiatric drug approvals (Abstract)

Brettler

Toward development of an abbreviated PANSS for pediatric trials New analyses of PANSS TEOSS data (Abstract)

Busner

Development of a Symbol Cancellation Test SCT for use in pediatric clinical trials in Sub-Saharan countries (Abstract)

Di Cesare

Development of a Cognitive Ability Assessment Tool CAAT for use in pediatric clinical trials in Sub-Saharan countries (Abstract)

Di Cesare

Proving the equivalence of simplified home sleep testing to polysomnography (Abstract)

Dorffner

Development of an algorithm for the evaluation of gait and balance impairments in CNS disorders (Abstract)

Ellis

Gathering normative speech data for depression research remotely using online task marketplaces (Abstract)

Fidalgo

Remote digital measurement of visual and auditory markers of major depressive disorder severity and treatment response (Abstract)

Galatzer-Levy

BI 425809 once daily in patients with schizophrenia feasibility of novel endpoints to assess motivation (Abstract)

Horan

Subgroup identification with Bayesian nonparametric models for individuals with schizophrenia at risk for relapse (Abstract)

Khan

Exploring the phenomenon of erratic ratings in schizophrenia clinical trials (Abstract)

Kott

Procedures to optimize endpoint data quality in an acute schizophrenia study (Abstract)

Kott

Personalising efficacy scales based on predominant symptoms at baseline (Abstract)

Laverdure-Dupont

Why some PANSS interviews are longer than others factors associated with PANSS interview length (Abstract)

Machizawa

Development of diagnostic criteria for apathy in neurocognitive disorders (Abstract)

Miller

Polygenic risk for Alzheimers disease predicts MMSE decline in APOE4 carriers and noncarriers (Abstract)

Moore

Biomarker guided treatment optimization in major depression focus on mineralocorticoid receptor function (Abstract)

Murck

Polygenic risk scores for bipolar disorders associated with worse global functioning (Abstract)

Paim Diaz

The impact of contextual factors on performance of a smartphone-based word list test (Abstract)

Parrish

Survey auditing based consistency checks to improve measurement with the PANSS (Abstract)

Rabinowitz

eCOA prompted MADRS interview balancing thorough assessment and efficiency (Abstract)

Roy

Signal detection and diagnostic uncertainty in bipolar depression trials drug vs placebo response (Abstract)

Sachs

Pandemic of professional subjects impact of recession on clinical trials (Abstract)

Shiovitz

Site ratings versus site-independent ratings of PANSS interviews in a schizophrenia study (Abstract)

Targum

Methodological successes and limitations in randomized delayed-start DREaM study comparing oral and injectable antipsychotics (Abstract)

Turkoz

Evaluating the impact of rater change on PANSS score change an item level analysis (Abstract)

Verma

Variability of cognitive performance on the MATRICS Consensus Cognitive Battery adding a different perspective (Abstract)

Williamson

Efficacy of BI 425809 in patients with schizophrenia phase II trial using multiple comparison procedure and modeling approach (Abstract)

Zhao